First-in-human experience of an antidote-controlled anticoagulant using RNA aptamer technology: a phase 1a pharmacodynamic evaluation of a drug-antidote pair for the controlled regulation of factor IXa activity (Q38307664)
Jump to navigation
Jump to search
scientific article
Language | Label | Description | Also known as |
---|---|---|---|
English | First-in-human experience of an antidote-controlled anticoagulant using RNA aptamer technology: a phase 1a pharmacodynamic evaluation of a drug-antidote pair for the controlled regulation of factor IXa activity |
scientific article |
Statements
1 reference
First-in-human experience of an antidote-controlled anticoagulant using RNA aptamer technology: a phase 1a pharmacodynamic evaluation of a drug-antidote pair for the controlled regulation of factor IXa activity (English)
1 reference
Steven R Steinhubl
1 reference
Robert A Harrington
1 reference
John H Alexander
1 reference
Neal S Kleiman
1 reference
Christopher K Dyke
1 reference
Richard O Cannon
1 reference
Laura G Aberle
1 reference
Min Lin
1 reference
Shelley K Myles
1 reference
Chiara Melloni
1 reference
Richard C Becker
1 reference
Christopher P Rusconi
1 reference
13 November 2006
1 reference
1 reference
114
1 reference
23
1 reference
2490-2497
1 reference
Identifiers
1 reference
1 reference